* Cerence Inc CRNC.OQ CRNC.O is expected to show a rise
in
quarterly revenue when it reports results for the period
ending June 30 2023
* The Burlington Massachusetts-based company is expected to
report a 26.2% increase in revenue to $73.377 million from
$58.14 million a year ago, according to the mean estimate from 9
analysts, based on LSEG data.The company's guidance on August 8
2023, for the period ended September 30, was for revenue between
72.00 million and 76.00 million.
* LSEG's mean analyst estimate for Cerence Inc is for
earnings of
15 cents per share. The company's EPS guidance on August 8 2023,
for the period ended September 30, was between 0.08 and 0.18
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Cerence Inc
is
$31.50, above its last closing price of $16.94.
The company's guidance on August 8 2023 for the period ended
September 30 was for Earnings before Interest and Taxes between
7.4 million and 11.4 million.The company's guidance on August 8
2023 for the period ended September 30 was for Earnings before
Interest, Taxes, Depreciation and Amortization of between 72
million and 13.5 million.The company's guidance on August 8 2023
for the period ended September 30 was for gross profit margin
between 72% and 73%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Jun. 30 2023 -0.14 -0.14 -0.04 Beat 71.3
Mar. 31 2023 -0.13 -0.13 -0.04 Beat 68.1
Dec. 31 2022 0.09 0.09 0.36 Beat 294.7
Sep. 30 2022 -0.23 -0.23 -0.14 Beat 38.8
Jun. 0.43 0.42 0.43 Beat 1.4
30 2022
Mar. 31 2022 0.34 0.34 0.33 Missed -3.8
Dec. 31 2021 0.51 0.51 0.59 Beat 16.7
Sep. 30 2021 0.57 0.56 0.66 Beat 16.9
This summary was machine generated November 24 at 12:09 GMT.
All figures in US dollars unless otherwise stated